Reinventing Drug Deliver 

Konstantinos Tzortzakis is the Co-founder and Chief Business Officer of Anodyne Nanotech, a biotechnology company revolutionizing drug delivery through transdermal systems. Anodyne Nanotech, a member of the Scale Up 3 Cohort, focuses on transforming traditional blockbuster treatments into more effective, non-invasive transdermal forms, addressing a critical need in modern healthcare.

Konstantinos’ passion for entrepreneurship was ignited early in his academic journey. While pursuing a Master of Science in Innovation and Management at Tufts University, he found inspiration not only in his studies but also through connections with his future co-founders. It was at Tufts that the seeds for Anodyne Nanotech were sown, with Konstantinos combining his technical background with an entrepreneurial drive. Prior to his time at Tufts, he earned a Master of Engineering in Electrical and Computer Engineering from the National Technical University of Athens, where he laid the groundwork for his future work in biotechnology.

This blend of engineering and business knowledge, paired with his experience in both the U.S. and Greek entrepreneurial ecosystems, has been essential in driving Anodyne Nanotech's mission forward. Konstantinos is dedicated to advancing the pharmaceutical landscape by improving biologic drug delivery, positioning his company as a front-runner in next-generation therapeutic technologies.